Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment

Our purpose was to identify tamoxifen (TAM) responsive genes after 30 days of TAM treatment in tumor tissues obtained from women with breast cancer using microarray expression analysis. In our study, we identified 12 candidates to be considered as tamoxifen-modulated genes. Among them, we selected two candidates the TEGT BI-1 (testis enhanced gene transcript Bax Inhibitor-1) and the CD63 gene in order to further confirm their differential expression under tamoxifen effects. We observed that both were down-regulated in tumor tissues of patients during TAM treatment. TEGT is able to inhibit the expression of Bax, which is known to promote apoptosis. On the other hand, CD63 encodes a cell membrane protein and it seems to be involved in mechanisms of platelet activation, cell adhesion and cell motility. We therefore hypothesize that TAM would be able to modulate tumor growth by down-regulating genes involved in mechanisms such as cell cycle control, tumor invasion and metastasis.

cDNA microarray analysis; Breast cancer; Tamoxifen

[1] Russo J., Calaf G., Sohi N., Tahin Q., Zhang P L., Alvarado M.E et al.: "Critical steps in breast carcinogenesis". Ann NY Acad Sci, 1993, 698, 1.

[2] Russo J., Yang X., Hu Y. F., Bove B., Huang Y., Silva I.D.C.G. et al.: "Biological and molecuar basis of human breast cancer". Front Biosci, 1998, 3, 944.

[3] Levenson A.S., Jordan V.C.: "Selective oestrogen modulation: molecular pharmacology for the millenium". Eur. J. Cancer, 1999, 35, 1628.

[4] Dardes R.C.M., Jordan V.C.: "Future directions in endocnne therapy for the treatment and prevention of breast cancer". Semin. Breast Dis., 2000, 3, 119.

[5] Samsioe G.: "Hormone replacement therapy: aspects of bleeding problems and compliance". Int. J. Fertil. Menopausal Stud., 1996, 41, 11.

[6] Mizuno K., Tanaka T., Ogita S.: "Inhibition of cAmp-mediated decidualization in human endometrial stromal cells by IL-lb and laminin". Horrn. Metab. Res., 1999, 31, 307.

[7] Clark G., Osborne C., McGuire W.: "Correlation between estrogen receptor, progesterone receptor, and patient characteristics in human breast". J. Clin. Oncol., 1984, 2, 1102.

[8] Fisher B., Constantino J.P., Wickerbaun D.L., Redmond C.K., Kavanah M., Cronin W.M. et al.: "Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel P roject P-1 Study". J. Natl Cancer Inst., 1998, 90, 1371.

[9] Camargo A.A. et al.: "The contribution of 700,000 ORF sequeuce tags to the definition of the human transcriptome". Proc. Natl Acad. Sci USA, 2001, 98, 12103.

[10] Claverie J.M.: "Computational methods for the identification of differential and coordinated gene expression". Hum. Mol. Genetics, 1999, 8, 1821.

[11] Silva I.D.C.G., Salicione A.M., Russo I.H., Higgy N.A., Gebnm L.H., Russo J.: "Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues". Cancer Res., 1997, 57, 378.

[12] Walter L., Dirks B., Rothermel E., Heyens M., Szpirer C., Levan G., Gunther E.: "A novel, conserved gene of the rat that is developmentally regulated in the testis". Mammalian Genome, 1994, 5, 216.

[13] Walter L., Marynen P., Szpirer J., Levan G., Gunther E.: "ldentification of a novel conserved human gene, T.E.G.T.". Genomics, 1995, 28, 301.

[14] Xu Q., Reed J.C.: "Bax inhibitor-1, a mammalian apoptos1s suppressor identified by functional screening in yeast". Malec. Cell., 1998, 1, 337.

[15] Sordat I., Decraene C., Silvestre T., P etermann 0., Auffray C., Pietu G., Sordat B:: "Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells". Lab Invest., 2002, 82, 1715.

[16] Wright M.D., Rochelle J.M., Tomlinson M.G., Seldin M.F., Williams A.F.: "Gene structure, chromosomal localization, and protein sequence of mouse CD53 (Cd53): evidence that the transmembrane 4 superfamily arose by gene duplication". Int Immunol., 1993, 5, 209.

[17] Ikeyama S., Koyama M., Yamaoko M., Sasada R., Miyake M. "Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP - l/CD9) DNA". J. Exp Med., 1993, 177, 1231.

[18] Radford K.J., Thorne R.F., Hersey P.: "CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta I integrins in human melanoma". Biochem. Biophys. Res. Commun., 1996, 222, 13.

[19] Stephen R., Corcoran D., Darbre P.D.: "A novel oestrogen-regulated gene in human breast cancer cells identified by differential display". J. Mol. Endocrinol., 1998, 20, 375.